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ABSTRACT. Objective: The aim of this study was to estimate costs
attributable to substance use and misuse in Canada in 2002. Method:
Based on information about prevalence of exposure and risk relations
for more than 80 disease categories, deaths, years of life lost, and hos-
pitalizations attributable to substance use and misuse were estimated.
In addition, substance-attributable fractions for criminal justice expen-
ditures were derived. Indirect costs were estimated using a modified hu-
man capital approach. Results: Costs of substance use and misuse
totaled almost Can. $40 billion in 2002. The total cost per capita for
substance use and misuse was about Can. $1,267: Can. $463 for alco-
hol, Can. $262 for illegal drugs, and Can. $541 for tobacco. Legal sub-
stances accounted for the vast majority of these costs (tobacco: almost
43% of total costs; alcohol: 37%). Indirect costs or productivity losses
were the largest cost category (61%), followed by health care (22%) and
law enforcement costs (14%). More than 40,000 people died in Canada
in 2002 because of substance use and misuse: 37,209 deaths were at-
tributable to tobacco, 4,258 were attributable to alcohol, and 1,695 were
attributable to illegal drugs. A total of about 3.8 million hospital days
were attributable to substance use and misuse, again mainly to tobacco.
Conclusions: Substance use and misuse imposes a considerable eco-
nomic toll on Canadian society and requires more preventive efforts.
(J. Stud. Alcohol Drugs 68: 886-895, 2007)
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THE BURDEN AND COST OF SUBSTANCE USE andmisuse in established market economies is enormous
(Anderson and Baumberg, 2006; Andlin-Sobocki and Rehm,
2005; Collins and Lapsley, 2002; Ezzati et al., 2002;
Harwood, 2000), and Canada is no exception. The last sys-
tematic estimate on the burden of substance use and mis-
use in Canada was undertaken a decade ago for the year
1992 (Single et al., 1996, 1998, 1999). The overall cost of
substance use and misuse for that year was estimated at
Can. $18.5 billion, which represented Can. $649 per capita.
Legal substances (i.e., alcohol and tobacco) accounted for
most of these costs. The study proved to be a valuable
resource for policy making and health care planning in
Canada. However, the study’s numbers have become out-
dated over the years, as changes have occurred in the Ca-
nadian population, in key health behaviors, in health
service-use patterns, and in law enforcement practices. To
fill this gap, the present study was initiated in 2003 and
finalized in 2006. In addition to providing economic data
relevant to health care planning, the study was conceptual-
ized to provide the basis for calculation of avoidable costs
resulting from a number of different policy changes (for
methodology of estimating avoidable costs see Collins et
al., 2006).
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Method
A brief description of the methodology will follow; how-
ever, for a detailed account of the study methodology, see
Rehm et al. (2006a).
Main approach of the study
This study was based on the revised International Guide-
lines for Estimating Costs of Substance Abuse (Single et
al., 2003) as a cost-of-illness study, in which the impact of
psychoactive substance use and misuse on the material wel-
fare of Canadian society in 2002 was examined relative to
a counterfactual scenario that assumed a situation of no
substance use and misuse. Usually, the term abuse is used
in economic literature, defined there as any substance use
that involves a social cost (Collins and Lapsley, 1991). As
the term abuse has a different definition in epidemiology
and substance use research, we decided to use the term use
and misuse, which covers costs attributable to all conse-
quences associated with the use of psychoactive substances,
rather than just those costs associated with physical depen-
dence or heavy use, or with substance-use disorder as de-
fined by the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (American Psychiatric Associa-
tion, 1995). This study used a modified prevalence-based
human capital approach based on the concept of opportu-
nity cost: The cost of resources spent on substance use and
misuse is the benefit forgone from their best alternate use.
Only social costs were included in this study. This ex-
cluded so-called private costs, that is, costs accrued by
people engaged in the activity of consuming psychoactive
substances (e.g., costs to buy cigarettes or beer). Intangible
costs (e.g., nonmonetary harms, such as pain and suffering)
were also excluded from the study. Costs avoided as a re-
sult of beneficial health effects of substance use (e.g.,
cardioprotective effect of regular moderate drinking with-
out heavy drinking occasions) were included, resulting in
the reporting of only net costs of substance use.
Estimating direct health care costs attributable to
substance use and misuse
The first step in estimating the health care costs was to
quantify the proportion of substance-attributable morbidity
and mortality. A list of more than 80 substance-attributable
disease conditions associated with substance use and mis-
use was developed from reviews of epidemiological litera-
ture (Rehm et al., 2006a) of alcohol (Rehm et al., 2006b),
illegal drugs (Popova et al., 2006b), and tobacco (Baliunas
et al., 2007). The epidemiological criteria for determining
which diseases were causally linked to substance use and
misuse were based on the usual epidemiological criteria,
with most weight accorded to consistency, biological mecha-
nism, strength of association, and temporality (English et
al., 1995; Hill, 1965; Rothman and Greenland, 1998). In
addition, diseases that are, by definition, fully attributable
to substance use and misuse (e.g., alcoholic cirrhosis of
liver) were identified in the International Classification of
Diseases Version 10 (ICD-10; World Health Organization,
2004).
Direct health care costs were estimated based on attrib-
utable fractions (AFs) (i.e., the proportion of a disease that
can be attributed to the use of a certain substance). The
AFs were calculated based on the prevalence of exposure
and the relative risk of different exposure categories com-
pared with no exposure using the following formula (see
Walter, 1976, 1980):
  
AF = −( )[ ] −( ) +[ ]= =∑ ∑P RR P RRi iik i iik1 1 11 0
where
• i is the exposure category with baseline exposure or
no exposure i = 0;
• RR(i) is the relative risk at exposure level i com-
pared with no consumption; and
• P(i) is the prevalence of the ith category of exposure.
The relative risks for each cause of disease and death
were taken from the most recent comprehensive meta-analy-
ses, separately by gender and age where applicable (see
Rehm et al., 2006a, for further details).
The prevalence data for alcohol were based on the Ca-
nadian Addiction Survey (Canadian Centre on Substance
Abuse, 2004) and adjusted for per capita consumption
(Rehm et al., 2006b, 2007). Data on smoking prevalence
were taken from the Canadian Community Health Survey
cycle 2.1 (Statistics Canada, 2003) and data on prevalence
of use of illegal drugs were collected from a variety of
Canadian federal and provincial institutions (Popova et al.,
2006a). For some disease categories, the AFs were derived
directly from available statistics, including traffic statistics
that categorize accidents that occur under the influence of
alcohol. AFs were derived specifically by gender, age, and
disease category. Based on the methodology, the AFs can be
negative if substance use prevents any deaths or morbidity.
AFs were then applied to the respective outcome (e.g.,
mortality, hospital days). Direct health care costs attribut-
able to substance use and misuse in all categories (hospi-
talizations, outpatient care, physician visits, and prescription
drugs) were calculated as the product of the aggregate units
of use, the average unit cost, and the disease-specific AF.
Sources of data for health services and their costs
Information on health service use was obtained from the
Canadian Institute for Health Information (CIHI). Number
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of specialized inpatient and outpatient admissions as well
as days of treatment of alcohol and illegal drug depen-
dency were obtained from provincial ministerial officials
or drug addiction program coordinators. The final report of
the cost study details the sources of information by service
category (Rehm et al., 2006a). CIHI data also provided the
average unit costs for these categories, in most cases both
on a national and provincial level.
Estimating direct costs of law enforcement attributable to
substance use and misuse
Law enforcement costs related to substance use and mis-
use include costs of policing, costs of the court system, and
costs of incarceration. Similar to the health sector, two cat-
egories of crimes could be distinguished. First, there were
offenses, which by definition are 100% attributable to sub-
stance use and misuse, such as drug offenses or drunk driv-
ing. Second, there are offenses where only a portion is
attributable to substance use and misuse; therefore, AFs
have to be determined. Consider property crime as an ex-
ample of this type of offense: Only a proportion of prop-
erty crime is related to substance use and misuse (e.g., when
a person engages in such crimes to finance his or her sub-
stance use). The proportion of nondrug crimes attributable
to alcohol and illegal drugs was based on the estimates
from the workgroup of Brochu and colleagues (2005). This
study was conducted as part of the second Canadian cost
study and provided gender-specific AFs for all crimes not
fully attributable to substance use and misuse. The data
were derived from interviews with a sample of federal and
provincial jail inmates (Brochu et al., 2005; see also
Pernanen et al., 2002). Inmates were given a standard in-
terview on drug and/or alcohol use and criminal behavior,
for the purposes of determining both immediate links and
past history. From these data, the causal contribution of
different substances in committing criminal offenses was
determined. Although the samples tried to cover some of
the variability with respect to severity and type of crime,
they cannot be considered fully representative for Canada.
Estimating indirect costs attributable to substance use and
misuse: Baseline method
The costs of productivity losses owing to substance-at-
tributable premature death or disability were estimated us-
ing a modified human capital method that assumes that a
pool of unemployed workers is available to replace the pre-
maturely deceased workers across a mean replacement pe-
riod of 3 months (Koopmanschap and Rutten, 1996).
Productivity losses were calculated as the sum of lost wages
during the replacement period and the monetized value of
replacement workers’ sacrifice of leisure for paid work,
assuming that the societal opportunity cost of their leisure
(i.e., the cost of forgone leisure) equals their marginal res-
ervation wage (i.e., the lowest wage at which they are will-
ing to work). To facilitate comparisons with past studies,
we also calculated productivity costs using the traditional
human capital method and the friction cost method
(Koopmanschap and Rutten, 1996).
This study used a 5% discount rate as this is the most
commonly used discount rate in costing studies and as such
maximizes comparability with other valuation studies. By
choosing 5% as the discount rate for the baseline analysis,
we followed the guidelines established by the Canadian Co-
ordinating Office for Health Technology Assessment (1997).
Productivity costs owing to premature mortality
Using the aggregate numbers of lost years of life by
gender and age group, the productivity cost of substance-
related premature mortality was calculated as the sum of
the cost to replace the deceased worker (estimated based
on gender-specific average wage, adjusted for gender- and
age-specific labor force participation) and the discounted
present value of the replacement worker’s projected future
stream of marginal reservation wages, adjusted for produc-
tivity growth as well as gender- and age-related labor force
participation.
Productivity costs owing to morbidity
To estimate the productivity losses attributable to sub-
stance-related morbidity, multivariate linear regression mod-
els of income were estimated using data recorded in the
Canadian Community Health Survey, Cycle 1.2 (CCHS
c1.2; Statistics Canada, 2002) for respondents ages 15-74
years. Productivity losses owing to morbidity were then
calculated as the difference between the predicted mean
income of the survey respondents with and without sub-
stance use disorders. Because the CCHS c1.2 did not mea-
sure tobacco-related disorders, the productivity losses owing
to tobacco use were calculated by multiplying the estimated
productivity losses owing to alcohol use and misuse (deter-
mined from the CCHS c1.2) by the ratio of hospitalization
days attributable to tobacco use to hospitalization days at-
tributable to alcohol use and misuse. We estimated the num-
ber and mean age of Canadians permanently disabled from
working owing to alcohol or illegal drug use and misuse
from CCHS c1.2 data and estimated their productivity losses
using methods similar to those for premature mortality.
Results
Epidemiological results
Morbidity. The morbidity results are summarized in Table
1. Overall, almost 18% of total acute care hospital days
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were the result of substance use and misuse in Canada 2002.
Alcohol caused about 6%, illegal drugs caused almost 2%,
and tobacco caused more than 10% of all hospital days.
Among Canadians younger than age 70, 19% of all hospi-
tal days were a result of substance use and misuse.
Table 2 presents the number of days spent in psychiatric
hospital and inpatient and outpatient specialized centers ow-
ing to substance use and misuse. Overall, about 2% of all
psychiatric hospital days were the result of alcohol use,
and about 1% the result of illegal drug use in Canada 2002.
Specialized treatment accounted for approximately 3 mil-
lion days each for alcohol and illegal drugs.
Mortality. Table 3 gives an overview of substance-at-
tributable mortality for Canada for the year 2002. Tobacco
caused more deaths than alcohol and illegal drugs com-
bined, although many of the tobacco-related deaths occurred
later in life. Alcohol-attributable deaths are a net estimate
that incorporates the cardioprotective effect of regular light
to moderate drinking (Rehm et al., 2003).
More than 19% of all deaths and about 30% of the deaths
among individuals younger than age 70 in Canada were
caused by substance use and misuse. This total represents a
slight overestimate owing to double-counting where there
is overlap between substance-attributable deaths. For ex-
ample, esophageal cancer is influenced by the interaction
of alcohol and tobacco use (Taylor and Rehm, 2005). How-
ever, the overall effect of this interaction between different
substances is not very large: Collins and Lapsley (2002)
found that the double-counting described above led to an
overestimate of 2.2% of the total mortality caused by ad-
dictive substances in Australia in 1998 and 1999.
Potential years of life lost. In 2002, Canadians lost about
516,000 potential years of life owing to tobacco, 148,000
years owing to alcohol, and 62,000 years owing to illegal
drugs, respectively representing about 17%, 5%, and 2% of
all potential life years lost by Canadians. Potential years of
life lost estimates are presented in Table 4.
Cost results
Table 5 gives an overview of the social costs attribut-
able to substance use and misuse by cost category for 2002.
The estimated cost of substance use and misuse in
Canada was Can. $39.8 billion in 2002. The economic costs
of tobacco use and misuse were estimated at Can. $17 bil-
lion. This represented almost 43% of total substance use
and misuse costs. Alcohol accounted for about Can. $14.6
billion in costs, which represented almost 37% of the total
costs of substance use and misuse. Costs of illegal drugs
were estimated to be approximately Can. $8.2 billion, which
represented almost 21% of the total costs of substance use
and misuse.
The total cost per capita for substance use and misuse
was about Can. $1,267 in 2002: Can. $463 for alcohol,
Can. $262 for illegal drugs, and Can. $541 for tobacco.
The two major direct cost categories attributable to sub-
stance use and misuse were health care costs, accounting
for more than 22% (Can. $8.8 billion), and costs for law
enforcement, accounting for about 14% (Can. $5.4 billion)
of the overall costs. Health care costs were by far the larg-
est category of direct costs, comprised mainly of costs aris-
ing from acute care hospitals but also from psychiatric and
other specialized treatment institutions. Although the ag-
gregate number of hospitalization days has declined mark-
edly in the last decade, aggregate hospital days attributable
to substance use and misuse did not follow this trend and
stayed at about the same level as in 1992 (Rehm et al.,
2006a). The costs of law enforcement attributable to sub-
stance use and misuse were considerable for both illegal
drugs and alcohol; overall, they constituted more than one
third of the total direct costs. Overall, the level of costs for
law enforcement attributable to substance use and misuse
can serve as an important marker that substance use and
misuse is not only a health problem but a larger public
health and social concern as well. Compared with the health
TABLE 2. Days spent in psychiatric hospitals and specialized treatment attributable to substance
use and misuse in Canada, 2002
Variable Alcohol Illegal drugsa Cannabis
Psychiatric treatment days
Males 38,602 21,881 2,895
Females 15,512 9,627 1,105
Total 54,114 31,508 4,000
All treatment days in Canada 1,432,547 2,110,102 –
% of substance-attributable treatment
days to all treatment days 1.53%. 0.89%. 0.11%.
Specialized treatment days
Males 2,102,148 1,832,510 –
Females 916,540 1,019,319 –
Total 3,018,688 2,851,829 –
aIncluding cannabis.
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TABLE 4. Potential years of life lost (PYLL) attributable to substance use and misuse in Canada,
2002, all ages
Variable M F Total % of all PYLL
Alcohol 113,380 34,191 147,571 4.77%
Illegal drugsa 42,306 19,805 62,110 2.01%
Cannabis 989 488 1,478 0.05%
Tobaccob 316,417 199,191 515,607 16.68%
Passive smoking 6,967 4,277 11,244 0.36%
Substance-attributable
PYLL 472,103 253,187 725,288
All PYLL in Canada 1,618,019 1,473,557 3,091,576
% of substance-attributable
PYLL 29.18% 17.18% 23.46%
Notes: Numbers for alcohol are net numbers (i.e., taking into consideration the beneficial effects
of alcohol use). M = male; F = female. aIncluding cannabis; bincluding passive smoking.
TABLE 5. The social costs of alcohol, illegal drugs and tobacco use and misuse in Canada, 2002, in
millions of Canadian dollars
Variable Alcohol Illegal drugs Tobacco Total ADT
1. Direct health care costs: total 3,306.2 1,134.6 4,360.2 8,800.9
1.1 Morbidity
- Acute care hospitalization 1,458.6 426.4 2,551.2 4,436.2
- Psychiatric hospitalization 19.6 11.5 – 31.2
1.2 Inpatient specialized treatment 754.9 352.1 – 1,107.1
1.3 Outpatient specialized treatment 52.4 56.3 – 108.7
1.4 Ambulatory care: physician fees 80.2 22.6 142.2 245.0
1.5 Family physician visit 172.8 48.8 306.3 527.9
1.6 Prescription drugs 767.6 216.8 1,360.5 2,344.9
2. Direct law enforcement costs 3,072.2 2,335.5 – 5,407.8
2.1 Police 1,898.8 1,432.0 – 3,330.7
2.2 Courts 513.1 330.6 – 843.7
2.3 Corrections (including probation) 660.4 573.0 – 1,233.4
3. Direct costs for prevention and research 53.0 16.5 78.1 147.6
3.1 Research 17.3 8.6 9.0 34.9
3.2 Prevention programs 33.9 7.9 69.1 110.9
3.3 Salaries and operating funds 1.8 – – 1.8
4. Other direct costs 996.1 79.1 87.0 1,162.2
4.1 Fire damage 156.5 – 86.5 243.0
4.2 Traffic accident damage 756.9 67.0 – 823.9
4.3 Losses associated with the workplace 17.0 6.6 0.5 24.1
4.3.1 EAP and health promotion
programs 17.0 4.2 0.5 21.7
4.3.2 Drug testing in the workplace – 2.4 NA 2.4
4.4 Administrative costs for transfer
payments 65.8 5.4 0.0 71.3
4.4.1 Social welfare and other
programs 4.3 – – 4.3
4.4.2 Workers’ compensation 61.5 5.4 – 66.9
5. Indirect costs: productivity losses
(main scenario) 7,126.4 4,678.6 12,470.9 24,275.9
5.1 Owing to long-term disability 6,163.9 4,408.4 10,536.8 21,109.1
5.2 Owing to short-term disability
(days in bed) 15.9 21.8 24.4 62.0
5.3 Owing to short-term disability
(days with reduced activity) 23.6 -0.1 36.2 59.8
5.4 Owing to premature mortality 923.0 248.5 1,873.5 3,045.0
Total 14,554.0 8,244.3 16,996.2 39,794.4
Total per capita, in Can. $ 463 262 541 1,267
Total as % of all substance-related costs 36.6% 20.7% 42.7% 100.0%
Notes: Categories in italics are sub-categories of immediate prior category. ADT = alcohol, illegal
drugs, and tobacco; NA = not applicable; “–” = not available; EAP = employee assistance programs.
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and the law enforcement sector, all the other direct costs
(e.g., prevention and research, fire damage, traffic accident
damage, losses associated with the workplace, and admin-
istrative costs for transfer payments) are of lesser economic
weight.
Based on the methods used in the baseline approach, the
productivity losses owing to substance use and misuse were
Can. $24.3 billion, constituting the largest part of the social
costs (61%). This finding is consistent with all previous
social cost studies of substance use and misuse (e.g., Collins
and Lapsley, 2002; Single et al., 1996). Among productiv-
ity losses the costs owing to long-term disability were the
largest component, at Can. $21.1 billion (87% of the total).
The methods used to calculate indirect costs are variable
and are the subject of ongoing debate. To facilitate com-
parisons with other studies, Table 6 presents sensitivity
analyses of indirect costs comparing the baseline approach
with the friction cost and traditional human capital meth-
ods. Depending on the method, the indirect cost estimates
range from Can. $567.9 million to Can. $39.2 billion. For
both the baseline approach and the traditional human capi-
tal method, indirect costs remain the largest social cost.
Discussion
There are several limitations of this study. For various
methodological reasons or simply because the data were
not available, some costs associated with substance use and
misuse were not included. Thus, prescription drug use and
misuse was not included simply because the minimum data
were not available in Canada to make a comprehensive
cost analysis.
Although this study represents an improvement in esti-
mating substance use and misuse costs linked to crime, it
could have benefited from more detailed policing data to
estimate enforcement costs. In the case of tobacco-related
crime, for example, no enforcement estimate was even pos-
sible, as there were no data that allow for the quantification
of this cost category, even though there clearly had been
law enforcement activities attributable to tobacco smuggling.
Finally, this study did not assess the lost productivity of
people in prison convicted of a substance-related crime.
The issue of causality with regard to alcohol-related
crime, and especially illegal drug-related crime, should be
also acknowledged as a limitation of this study. For ex-
ample, even in cases where a person consumed alcohol or
illegal drugs before committing a crime and even when the
respondent admitted that the crime would not have taken
place without them, there is no certainty that the crime can
be causally attributed to alcohol or drug consumption. Thus,
the attribution of alcohol or drugs as a causal factor in the
crime may contain bias, reflecting the limitations of the
methodologies used, which are based on self-report.
There are several approaches used in the economic cost
studies, including the human-capital approach, the friction-
cost approach, and the hybrid approach. In this study, the
latter approach was used as the best suitable method for
current labor market conditions in Canada. The hybrid ap-
proach assumes availability of replacement workers (labor
markets in Canada are not at full employment); thus, the
value of societal production losses resulting from prema-
ture deaths is equal to the production lost during the re-
placement (friction) period plus the value of leisure
sacrificed by replacement workers. The human-capital ap-
proach overestimates the value of societal losses by assum-
ing the loss is permanent—that the prematurely deceased
workers cannot be replaced. The underlying assumption of
full employment is not realistic in contemporary Canadian
labor markets, where involuntary unemployment has been
a persistent feature over several years. The friction-cost ap-
proach underestimates the production losses, as it assumes
that the societal opportunity cost of labor is zero—that is,
that the sacrifice of replacement workers’ leisure for work
has no monetary value. The hybrid approach recognizes
both the value of leisure sacrificed for work as well as
existing involuntary unemployment.
At almost Can. $40 billion in 2002, the social costs of
substance use and misuse in Canada were considerable, and
they appear to have increased over the past decade, par-
ticularly for illegal drugs. Neither these recent costs nor the
trend of increasing social costs is necessary, as the inter-
vention literature demonstrates that there are numerous fea-
sible, cost-effective, and evidence-based approaches to
reducing substance-attributable costs. For example, alcohol
control measures such as pricing, taxation, state monopo-
lies to prevent selling to minors, and strict and consistent
enforcement of traffic and workplace safety laws have been
shown to be effective and cost-effective (Babor et al., 2003;
Chisholm et al., 2004) methods to contain or reduce the
social costs of alcohol. For tobacco, interventions such as
TABLE 6. Sensitivity analyses of substance-attributable indirect costs (in
millions of Canadian dollars)
Friction Human-
Main -cost capital
Variable scenario approach  approach
Costs of productivity losses
owing to long-term disability
Alcohol 6,163.9 133.1 9,848.5
Illegal drugs 4,408.4 93.1 7,046.9
Tobacco 10,536.8 235.9 16,821.6
Total 21,109.1 462.1 33,717.0
Costs of productivity losses
owing to premature mortality
Alcohol 923.0 30.0 1,822.7
Illegal drugs 248.5 7.2 468.6
Tobacco 1,873.5 68.7 3,148.6
Total 3,045.0 105.8 5,440.0
Total 24,154.1 567.9 39,157.0
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taxation, clean indoor air laws, a comprehensive ban on
advertising, and dissemination of information on the health
risks of tobacco have also been shown to be cost effective
in all World Health Organization subregions (Shibuya et
al., 2003). Indeed, some of the reduced burden of disease
in Canada can probably be attributed to the improved to-
bacco control measures over the past decade. For illegal
drugs, the evidence is much less clear, but some countries
such as Switzerland (Büechi and Minder, 2001), France,
and Spain (Ramirez-Jonville, 2006) seem to have devel-
oped effective strategies to reduce harm and costs from
illegal drugs.
Estimating social costs is important not only for under-
standing current realities but also for future programming
and policy. However, estimating social costs is only the
first step in future planning. For concrete programming and
policy making, it is necessary to know which social costs
are avoidable costs. The costs presented in this article ag-
gregate all costs attributable to substance use and misuse,
no matter whether or to what degree they are avoidable. To
give one example, if all tobacco consumption stopped to-
day, there would still be tobacco-attributable lung cancers
for many years to come. There are many other examples,
and, in the past year, there have been efforts to systemati-
cally determine the avoidable costs attributable to substance
use and misuse (Collins et al., 2006; Rehm et al., 2006c).
Given the level of substance use- and misuse-related costs
in Canada, it is important to start the work on quantifying
avoidable costs to have more focused and relevant infor-
mation from which to plan programs and policies to reduce
these costs.
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